Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

How I treat pediatric venous thromboembolism in the DOAC era

Rukhmi V. Bhat, Guy Young, Anjali A. Sharathkumar

Blood (2024) 143 (5): 389–403.

https://doi.org/10.1182/blood.2022018966

Published: 2024

Journal Articles

Mavorixafor for Patients with Chronic Neutropenic Disorders Treated with G-CSF: Preliminary Response Data and G-CSF Dose Reduction in an Ongoing Phase 2, Open-Label, Multicenter Study Support Reduction in G-CSF Dosing

Julia T. Warren, Kathryn E. Dickerson, Anjali A. Sharathkumar, Jolan E. Walter, David B. Wilson, Katrina P. Adell, Kelly Chen, Susan Dubuc, Rick MacLeod, Katie Peters, Murray Stewart, Arthur G. Taveras, Kelly Walkovich

Blood (2023) 142 (Supplement 1): 1160.

https://doi.org/10.1182/blood-2023-173549

Published: 2023

Journal Articles

Risk Factors for Joint Bleeding in Severe Hemophilia a and B: Analysis of the Community Counts Longitudinal Surveillance Cohort

Marilyn Manco-Johnson, Suchitra Acharya, Sanjay Ahuja, Meera Chitlur, Divyaswathi Citla Sridhar, Stacey Fedewa, Daniel Isaac, Roshni Kulkarni, Laura Schieve, Anjali A. Sharathkumar, Binh Le, Mike Soucie

Blood (2023) 142 (Supplement 1): 287.

https://doi.org/10.1182/blood-2023-179850

Published: 2023

Journal Articles

An Expanded Post-Thrombosis Sequelae Assessment Scale in Children.

Anjali A. Sharathkumar, MD, Dave Van Mater, MD,PhD, Derek Demscheff, PhD, Steven W. Pipe, MD

Blood (2007) 110 (11): 3196.

https://doi.org/10.1182/blood.V110.11.3196.3196

Published: 2007

Journal Articles

Prevention of Early Arteriovenous Fistula Failure Due to Thromosis: Experience with Primary Thromboprophylaxis.

Anjali A. Sharathkumar, MD, Jin-Jar Lin, MD, PhD, Ronald Hirschl, MD, Steven Pipe, MD

Blood (2006) 108 (11): 885.

https://doi.org/10.1182/blood.V108.11.885.885

Published: 2006

NARROW

How I treat pediatric venous thromboembolism in the DOAC era

Mavorixafor for Patients with Chronic Neutropenic Disorders Treated with G-CSF: Preliminary Response Data and G-CSF Dose Reduction in an Ongoing Phase 2, Open-Label, Multicenter Study Support Reduction in G-CSF Dosing

Risk Factors for Joint Bleeding in Severe Hemophilia a and B: Analysis of the Community Counts Longitudinal Surveillance Cohort

An Expanded Post-Thrombosis Sequelae Assessment Scale in Children.

Prevention of Early Arteriovenous Fistula Failure Due to Thromosis: Experience with Primary Thromboprophylaxis.

Email alerts

ASH Publications

American Society of Hematology

How I treat pediatric venous thromboembolism in the DOAC era

Mavorixafor for Patients with Chronic Neutropenic Disorders Treated with G-CSF: Preliminary Response Data and G-CSF Dose Reduction in an Ongoing Phase 2, Open-Label, Multicenter Study Support Reduction in G-CSF Dosing

Risk Factors for Joint Bleeding in Severe Hemophilia a and B: Analysis of the Community Counts Longitudinal Surveillance Cohort

An Expanded Post-Thrombosis Sequelae Assessment Scale in Children.

Prevention of Early Arteriovenous Fistula Failure Due to Thromosis: Experience with Primary Thromboprophylaxis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only